Filing Details
- Accession Number:
- 0001593968-21-000076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-06 20:48:05
- Reporting Period:
- 2021-01-05
- Accepted Time:
- 2021-01-06 20:48:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1673772 | Rapt Therapeutics Inc. | RAPT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1635616 | G. Dirk Brockstedt | C/O Rapt Therapeutics, Inc., 561 Eccles Avenue South San Francisco CA 94080 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-05 | 821 | $19.76 | 18,735 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-06 | 1,179 | $19.68 | 17,556 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares.
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.